Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.17 (
lysozyme
)
21,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of pyrophosphate ions (PP: P2O7(4-)) on the adsorption of proteins onto calcium hydroxyapatite (Hap) were examined using typical proteins of bovine serum albumin (BSA: isoelectric point (iep) = 4.7, molecular mass (M(s)) = 67 200 Da, acidic protein), myoglobin (MGB: iep = 7.0, M(s) = 17 800 Da, neutral protein), and
lysozyme
(LSZ: iep = 11.1, M(s) = 14,600 Da, basic protein). The UV and CD measurements determined that both the secondary and the tertiary structures of protein molecules do not vary in the presence of PP. The adsorption of BSA was strongly depressed by the addition of PP in all the methods with changing the order of PP addition. Even if BSA was pre-adsorbed on the Hap surface, PP replaced BSA molecules by strong preferential adsorption onto Hap to reduce the amounts of adsorbed BSA. A similar effect was observed with the adsorption of MGB. On the other hand, the amount of adsorbed LSZ (n(LSZ)) was increased with an increase in the concentration of PP, and the n(LSZ) value showed a maximum point in each adsorption isotherm. This fact was explained by a compression of the electric double layer (EDL) around each LSZ molecule by PP. This compression of the EDL induced the reduction of lateral electrostatic repulsions between charged LSZ molecules on the Hap surface and enhanced the formation of closed-packed monolayers to raise the n(LSZ) value. However, since the number of PPs around a LSZ molecule is decreased by an increase in the LSZ concentration in each system, the thickness of the EDL may be increased. Hence, n(LSZ) was reduced again after the maximum point in each system. Tripolyphosphate (
TPP
: P3O10(5-)) ions exhibited similar effects on the adsorption behaviors of all proteins, but a much more pronounced effect was observed on the LSZ system.
TPP
with a higher eletronegativity shielded the EDL more highly than PP to increase the n(LSZ) value. The results of the zeta potential for all the protein systems supported the modes of protein adsorption discussed.
...
PMID:Effects of pyrophosphate ions on protein adsorption onto calcium hydroxyapatite. 1823 62
Protein affinity is of importance for porphyrins in their application in photodynamic therapy (PDT). A new Phenol Red-modified porphyrin (R-
TPP
) was designed and synthesized to fully take advantage of the binding character of Phenol Red towards protein. Detailed comparisons of absorption spectra, fluorescence spectra, n-octanol/water partition coefficients, (1)O(2) quantum yields, as well as protein photocleaving abilities between R-
TPP
and its parent porphyrin Br-
TPP
clearly demonstrate the benefits stemming from the modification of Phenol Red. On one hand, the presence of Phenol Red moiety greatly enhances the binding affinity of R-
TPP
towards model proteins (bovine serum albumin and hen egg
lysozyme
), and therefore improves the availability of (1)O(2). On the other hand, the presence of Phenol Red moiety provides R-
TPP
with amphiphilic character, and therefore restricts aggregation and favors the generation of (1)O(2). As a result, R-
TPP
photocleaves proteins efficiently, showing promising application potential in PDT.
...
PMID:A new Phenol Red-modified porphyrin as efficient protein photocleaving agent. 2071 77
A simple method for the functionalization of a common implant material (Ti6Al4V) with biodegradable, drug loaded chitosan-tripolyphosphate (CS-TPP) nanoparticles is developed in order to enhance the osseointegration of endoprostheses after revision operations. The chitosan used has a tailored degree of acetylation which allows for a fast biodegradation by
lysozyme
. The degradability of chitosan is proven via viscometry. Characteristics and degradation of nanoparticles formed with
TPP
are analyzed using dynamic light scattering. The particle degradation via
lysozyme
displays a decrease in particle diameter of 40% after 4 days. Drug loading and release is investigated for the nanoparticles with bone morphogenetic protein 2 (BMP-2), using ELISA and the BRE luciferase test for quantification and bioactivity evaluation. Furthermore, nanoparticle coatings on titanium substrates are created via spray-coating and analyzed by ellipsometry, scanning electron microscopy and X-ray photoelectron spectroscopy. Drug loaded nanoparticle coatings with biologically active BMP-2 are obtained in vitro within this work. Additionally, an in vivo study in mice indicates the dose dependent induction of ectopic bone growth through CS-
TPP
-BMP-2 nanoparticles. These results show that biodegradable CS-
TPP
coatings can be utilized to present biologically active BMP-2 on common implant materials like Ti6Al4V.
...
PMID:Biodegradable chitosan nanoparticle coatings on titanium for the delivery of BMP-2. 2558 89